Search Results

There are 4598 results for: content related to: Long-term oral mesalazine adherence and the risk of disease flare in ulcerative colitis: nationwide 10-year retrospective cohort from the veterans affairs healthcare system

  1. You have free access to this content
    Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 6, September 2015, Pages: 664–684, A. Tursi, A. Papa and S. Danese

    Version of Record online : 22 JUL 2015, DOI: 10.1111/apt.13322

  2. You have free access to this content
    Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation – a placebo-controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 3, August 2013, Pages: 264–273, M. Watanabe, H. Nishino, Y. Sameshima, A. Ota, S. Nakamura and T. Hibi

    Version of Record online : 5 JUN 2013, DOI: 10.1111/apt.12362

  3. You have free access to this content
    Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon – a placebo-controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 7, April 2013, Pages: 680–690, W. Kruis, E. Meier, M. Schumacher, O. Mickisch, R. Greinwald, R. Mueller and the German SAG-20 Study Group

    Version of Record online : 17 FEB 2013, DOI: 10.1111/apt.12248

  4. You have free access to this content
    Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 11, June 2015, Pages: 1055–1065, L. Moja, S. Danese, G. Fiorino, C. Del Giovane and S. Bonovas

    Version of Record online : 13 APR 2015, DOI: 10.1111/apt.13190

  5. You have full text access to this OnlineOpen article
    Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence

    Alimentary Pharmacology & Therapeutics

    Volume 46, Issue 3, August 2017, Pages: 282–291, W. Kruis, V. Kardalinos, T. Eisenbach, M. Lukas, T. Vich, I. Bunganic, J. Pokrotnieks, J. Derova, J. Kondrackiene, R. Safadi, D. Tuculanu, Z. Tulassay, J. Banai, A. Curtin, A. E. Dorofeyev, S. F. Zakko, N. Ferreira, S. Björck, M. M. Diez Alonso, J. Mäkelä, N. J. Talley, K. Dilger, R. Greinwald, R. Mohrbacher and R. Spiller

    Version of Record online : 23 MAY 2017, DOI: 10.1111/apt.14152

  6. You have free access to this content
    Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 3, August 2013, Pages: 284–293, S. Vegter, K. Tolley, T. Wilson Waterworth, H. Jones, S. Jones and D. Jewell

    Version of Record online : 10 JUN 2013, DOI: 10.1111/apt.12369

  7. You have free access to this content
    Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 8, April 2013, Pages: 767–775, B. Flourié, H. Hagège, G. Tucat, D. Maetz, X. Hébuterne, J. P. Kuyvenhoven, T. G. Tan, M. J. Pierik, A. A. M. Masclee, O. Dewit, C. S. Probert, D. Aoucheta and the MOTUS study investigators

    Version of Record online : 4 MAR 2013, DOI: 10.1111/apt.12266

  8. You have free access to this content
    Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease – a double-blind, randomised, placebo-controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 7, October 2013, Pages: 741–751, A. Tursi, G. Brandimarte, W. Elisei, M. Picchio, G. Forti, G. Pianese, S. Rodino, T. D'Amico, N. Sacca, P. Portincasa, E. Capezzuto, R. Lattanzio, A. Spadaccini, S. Fiorella, F. Polimeni, N. Polimeni, V. Stoppino, G. Stoppino, G. M. Giorgetti, F. Aiello and S. Danese

    Version of Record online : 19 AUG 2013, DOI: 10.1111/apt.12463

  9. You have free access to this content
    Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis – a double-blind, double-dummy study

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 5, September 2013, Pages: 490–500, J. Langhorst, I. Varnhagen, S. B. Schneider, U. Albrecht, A. Rueffer, R. Stange, A. Michalsen and G. J. Dobos

    Version of Record online : 4 JUL 2013, DOI: 10.1111/apt.12397

  10. Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 3, February 2016, Pages: 400–426, F. Fernández-Bañares, M. J. Casanova, Y. Arguedas, B. Beltrán, D. Busquets, J. M. Fernández, L. Fernández-Salazar, E. García-Planella, D. Guagnozzi, A. J. Lucendo, N. Manceñido, I. Marín-Jiménez, M. Montoro, M. Piqueras, V. Robles, A. Ruiz-Cerulla, J. P. Gisbert and on behalf of the Spanish Microscopic Colitis Group (SMCG)

    Version of Record online : 24 NOV 2015, DOI: 10.1111/apt.13477

  11. You have free access to this content
    Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 46, Issue 3, August 2017, Pages: 292–302, G. R. D'Haens, W. J. Sandborn, G. Zou, L. W. Stitt, P. J. Rutgeerts, D. Gilgen, V. Jairath, P. Hindryckx, L. M. Shackelton, M. K. Vandervoort, C. E. Parker, C. Muller, R. K. Pai, O. Levchenko, Y. Marakhouski, M. Horynski, E. Mikhailova, N. Kharchenko, S. Pimanov and B. G. Feagan

    Version of Record online : 1 JUN 2017, DOI: 10.1111/apt.14164

  12. You have full text access to this OnlineOpen article
    Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 5, September 2013, Pages: 531–538, A. Robinson, M. Hankins, G. Wiseman and M. Jones

    Version of Record online : 8 JUL 2013, DOI: 10.1111/apt.12396

  13. You have free access to this content
    Systematic review: the efficacy of herbal therapy in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 8, October 2013, Pages: 854–863, S. C. Ng, Y. T. Lam, K. K. F. Tsoi, F. K. L. Chan, J. J. Y. Sung and J. C. Y. Wu

    Version of Record online : 25 AUG 2013, DOI: 10.1111/apt.12464

  14. You have free access to this content
    Review article: ulcerative colitis, smoking and nicotine therapy

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 11-12, December 2012, Pages: 997–1008, P. C. Lunney and R. W. L. Leong

    Version of Record online : 16 OCT 2012, DOI: 10.1111/apt.12086

  15. Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 10, November 2016, Pages: 1018–1029, G. D'Haens

    Version of Record online : 21 SEP 2016, DOI: 10.1111/apt.13803

  16. You have free access to this content
    Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 5, September 2015, Pages: 549–558, T. Yamamoto, T. Shimoyama and K. Matsumoto

    Version of Record online : 3 JUL 2015, DOI: 10.1111/apt.13308

  17. You have free access to this content
    Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis – a pooled analysis

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 9, November 2011, Pages: 1115–1122, L. Leifeld, R. Pfützer, J. Morgenstern, P. R. Gibson, Y. Marakhouski, R. Greinwald, R. Mueller and W. Kruis

    Version of Record online : 19 SEP 2011, DOI: 10.1111/j.1365-2036.2011.04840.x

  18. Is Once-Daily Mesalazine Equivalent to the Currently Used Twice-Daily Regimen? A Study Performed in 30 Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 47, Issue 3, March 2007, Pages: 334–342, Dr Peggy Gandia, Dr Isabelle Idier and Dr Georges Houin

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006296522

  19. You have free access to this content
    Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 9, November 2014, Pages: 991–1008, H. Schulze, P. Esters and A. Dignass

    Version of Record online : 9 SEP 2014, DOI: 10.1111/apt.12949

  20. Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 45, Issue 9, May 2017, Pages: 1179–1192, S. Bonovas, G. Fiorino, T. Lytras, G. Nikolopoulos, L. Peyrin-Biroulet and S. Danese

    Version of Record online : 6 MAR 2017, DOI: 10.1111/apt.14023